Abstract
Systematic screening for diabetic retinopathy using retinal photography has been shown to reduce the incidence of blindness among people with diabetes. The implementation of diabetic retinopathy screening programmes faces several challenges. Consequently, methods for improving the efficiency of screening are being sought, one of which is the automation of image grading involving detection of images with either disease or of inadequate quality using computer software. This review aims to bring together the available evidence that is suitable for making a judgement about whether automated grading systems could be used effectively in diabetic retinopathy screening. To do this, it focuses on studies made by the few centres who have presented results of tests of automated grading software on large sets of patients or screening episodes. It also considers economic model analyses and papers describing the effectiveness of manual grading in order that the effect of replacing stages of manual grading by automated grading can be judged. In conclusion, the review shows that there is sufficient evidence to suggest that automated grading, operating as a disease / no disease grader, is safe and could reduce the workload of manual grading in diabetic retinopathy screening.
Keywords: Diabetic retinopathy, Screening, Computer-assisted image analysis, Imaging, Telemedicine, Automated grading, Blindness, Slit-lamp examination, Microaneurysm detection, Haemorrhage
Current Diabetes Reviews
Title: The Evidence for Automated Grading in Diabetic Retinopathy Screening
Volume: 7 Issue: 4
Author(s): Alan D. Fleming, Sam Philip, Keith A. Goatman, Gordon J. Prescott, Peter F. Sharp and John A. Olson
Affiliation:
Keywords: Diabetic retinopathy, Screening, Computer-assisted image analysis, Imaging, Telemedicine, Automated grading, Blindness, Slit-lamp examination, Microaneurysm detection, Haemorrhage
Abstract: Systematic screening for diabetic retinopathy using retinal photography has been shown to reduce the incidence of blindness among people with diabetes. The implementation of diabetic retinopathy screening programmes faces several challenges. Consequently, methods for improving the efficiency of screening are being sought, one of which is the automation of image grading involving detection of images with either disease or of inadequate quality using computer software. This review aims to bring together the available evidence that is suitable for making a judgement about whether automated grading systems could be used effectively in diabetic retinopathy screening. To do this, it focuses on studies made by the few centres who have presented results of tests of automated grading software on large sets of patients or screening episodes. It also considers economic model analyses and papers describing the effectiveness of manual grading in order that the effect of replacing stages of manual grading by automated grading can be judged. In conclusion, the review shows that there is sufficient evidence to suggest that automated grading, operating as a disease / no disease grader, is safe and could reduce the workload of manual grading in diabetic retinopathy screening.
Export Options
About this article
Cite this article as:
D. Fleming Alan, Philip Sam, A. Goatman Keith, J. Prescott Gordon, F. Sharp Peter and A. Olson John, The Evidence for Automated Grading in Diabetic Retinopathy Screening, Current Diabetes Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339911796397802
DOI https://dx.doi.org/10.2174/157339911796397802 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting Tumor Proteasome with Traditional Chinese Medicine
Current Drug Discovery Technologies Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (<sup>99m</sup>Tc-HMDP) Bone Scintigraphy for Bone Metastases from Prostate Cancer Using Deep Learning Algorithms
Current Medical Imaging Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions
Current Drug Metabolism The HGF-Met Signaling Axis: Emerging Themes and Targets of Inhibition
Current Protein & Peptide Science The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
Current Drug Targets Human Sirtuins: An Overview of an Emerging Drug Target in Age-Related Diseases and Cancer
Current Drug Targets Immunobiologic Agents in Dermatology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Meet Our Editorial Board Member
Current Drug Therapy siRNA Delivery Using Nanocarriers – An Efficient Tool for Gene Silencing
Current Gene Therapy NHE-1: A Promising Target for Novel Anti-cancer Therapeutics
Current Pharmaceutical Design 1, 3, 6-Trihydroxy-7-Methyl-9, 10-Anthracenedione Isolated from genus Lindera with Anti-Cancer Activity
Anti-Cancer Agents in Medicinal Chemistry Rational Targeting of Peroxisome Proliferating Activated Receptor Subtypes
Current Medicinal Chemistry Polyphenols and Aging
Current Aging Science Oncogenic Properties of HIV-Tat in Colorectal Cancer Cells
Current HIV Research Chemotherapy and Delivery in the Treatment of Primary Brain Tumors
Current Clinical Pharmacology Polymer-Based Drug Delivery Systems, Development and Pre-Clinical Status
Current Pharmaceutical Design Molecular Imaging Aided Improvement in Drug Discovery and Development
Current Biotechnology The Janus Face of Cathelicidin in Tumorigenesis
Current Medicinal Chemistry A Study of Correlation between Anti-peroxidative Potential of Quercetin and Ascorbic Acid with Malondialdehyde by RP-HPLC
Current Chemical Biology Transcriptional Regulation by Promoter Targeted RNAs
Current Topics in Medicinal Chemistry